SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Lotus Pharmaceuticals, Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) With the U.S. Lotus Pharmaceuticals, Inc.